Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Inventurus Knowledge Solutions Ltd.

IKS

Equity

NSE,BSE

Min. Investment

12,65,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Google PlayApp Store

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

12 Dec 24 - 16 Dec 24

Price Range ₹

1265 - 1329

Total Equity

1377.75Cr

Lot Size

11

Exchange Status

NSE,BSE

IPO Doc

Subscription Rate

Non-Institutional Investor

14.55×

Qualified Institutional Buyers

80.64×

Employees

5.20×

Retail Investors

14.55×

Total subscription Rate

52.68×

IPO Timeline

Offer start

12 Dec 2024

Offer end

16 Dec 2024

Allotment

17 Dec 2024

Refund initiation

18 Dec 2024

Demat transfer

18 Dec 2024

Listing

19 Dec 2024

About Company

Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a healthcare technology company specializing in reducing administrative burdens for healthcare providers while improving patient care delivery. The company offers a comprehensive platform with services such as clinical support, virtual medical scribing, and medical documentation management, catering to both outpatient (ambulatory care) and inpatient care needs. Serving over 778 healthcare organizations, including notable clients like Mass General Brigham Inc. and Texas Health Care PLLC, IKS employs 13,528 team members, including 2,612 clinically trained professionals, across the US, Canada, and Australia. Its competitive strengths include a diversified service portfolio, advanced digital and automation technologies, a strong brand reputation among healthcare providers, and a scalable, cost-efficient business model fostering client flexibility and cross-selling opportunities.

Year Founded

05-09-2006

Promotor Details

Berjis Minoo Desai

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage69.7363.72
Share Capital119642752109328542

Offer to Public

1,03,66,780.00 Cr

Project Details

  • None - Nonecr

Objectives

  • The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.

Highlights

  • The leadership team comprises experienced professionals, providing strategic direction and deep industry expertise.
  • The company maintains long-standing relationships with major healthcare providers and organizations, driving consistent revenue and cross-selling opportunities
  • Its scalable business model enables cost-efficient operations, enhancing overall profitability.
  • IKS leverages a strong brand reputation and advanced digital technologies to sustain growth and deliver value.
  • IKS Health offers services across outpatient and inpatient care, administrative support, and clinical documentation, ensuring diverse revenue streams and reducing reliance on a single source.

Challenges

  • Operating in multiple jurisdictions poses regulatory compliance challenges that could affect profitability and operations.
  • Healthcare spending is influenced by economic conditions, and a slowdown in global healthcare budgets could impact IKS Health’s revenue.
  • The healthcare technology sector is highly competitive, with both established and emerging players vying for market share.
  • The IPO is structured as an Offer for Sale, with no fresh capital being infused into the company.
  • High promoter shareholding may have implications for investor decision-making and future governance.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS
20227,105.28168.079,316.749,316.745.7735
202038,593.99805.4013,746.6613,746.668.4496
202428,520.68169.219,316.749,316.745.7735
202152,432.96810.8823,34,38,480.0023,34,38,430.001.4016
20238,935.75168.3613,746.6613,746.668.4496
Enrich money logo